IN2014CH00269A - - Google Patents

Info

Publication number
IN2014CH00269A
IN2014CH00269A IN269CH2014A IN2014CH00269A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A IN 269CH2014 A IN269CH2014 A IN 269CH2014A IN 2014CH00269 A IN2014CH00269 A IN 2014CH00269A
Authority
IN
India
Prior art keywords
retigabine
present application
modification
relates
crystalline
Prior art date
Application number
Inventor
Srinivasulu Rangineni
Sunitha Vyala
Satish Kumar Vujjini
Ramesh Chakka
Original Assignee
Reddy’S Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy’S Lab Ltd Dr filed Critical Reddy’S Lab Ltd Dr
Priority to IN269CH2014 priority Critical patent/IN2014CH00269A/en
Publication of IN2014CH00269A publication Critical patent/IN2014CH00269A/en

Links

Abstract

The present application relates to process for the preparation of Retigabine crystalline modification A and modification C. The present application also relates to the mixture of crystalline modifications of Retigabine and pharmaceutical compositions thereof.
IN269CH2014 2014-01-21 2014-01-21 IN2014CH00269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (en) 2014-01-21 2014-01-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN269CH2014 IN2014CH00269A (en) 2014-01-21 2014-01-21

Publications (1)

Publication Number Publication Date
IN2014CH00269A true IN2014CH00269A (en) 2015-08-14

Family

ID=54393600

Family Applications (1)

Application Number Title Priority Date Filing Date
IN269CH2014 IN2014CH00269A (en) 2014-01-21 2014-01-21

Country Status (1)

Country Link
IN (1) IN2014CH00269A (en)

Similar Documents

Publication Publication Date Title
IN2014CH00247A (en)
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
MX2019015744A (en) Pharmaceutical compositions.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
EP3102554A4 (en) Conversion of 2,3-butanediol to butadiene
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
MX2020009444A (en) Low dose oral pharmaceutical composition of isotretinoin.
IN2013MU03641A (en)
IN2013MU00646A (en)
EP3212620A4 (en) Process for the preparation of apixaban and intermediates thereof
MA40313A (en) Oral pharmaceutical composition of isotretinoin
MX2017015137A (en) Once daily oral pharmaceutical composition of isotretinoin.
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
IN2014MU00455A (en)
EP3229791A4 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
IN2014CH00840A (en)
GEP20196974B (en) A novel crystalline form of a benzimidazole derivative and a preparation method thereof
PL3236764T3 (en) Process for the preparation of spice compositions
MX2016015465A (en) Oral pharmaceutical composition of isotretinoin.
MX2016009667A (en) Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.
MA40447A (en) Oral pharmaceutical composition of isotretinoin
GB2559718B (en) Novel crystalline form of tribenuron-methyl, process for preparation and use thereof
IL237572A0 (en) Process and intermediates for the preparation of dasatinib
MX2015011881A (en) Process for the preparation of 3,7-dimethylnonan-1-ol.
IN2013MU02528A (en)